Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Parkinson's Disease

  Free Subscription


Articles published in Neurobiol Dis

Retrieve available abstracts of 117 articles:
HTML format



Single Articles


    September 2025
  1. RODICHKIN AN, Brown AM, Devabathini P, McGlothan JL, et al
    Cerebellar dysfunction in a mouse model of childhood-onset manganese-induced dystonia parkinsonism.
    Neurobiol Dis. 2025;216:107115.
    PubMed     Abstract available


  2. LI P, Zhou X, Luo N, Zhou S, et al
    Dynamic cortical inhibition imbalance as a biomarker of clinical progression in early Parkinson's disease.
    Neurobiol Dis. 2025 Sep 3:107083. doi: 10.1016/j.nbd.2025.107083.
    PubMed     Abstract available


  3. DUBACH L, Averna A, Alva L, Debove I, et al
    Unconsciousness reshapes the oscillatory topography of the subthalamic nucleus: A comparative study.
    Neurobiol Dis. 2025;213:107009.
    PubMed     Abstract available


    August 2025
  4. BHARTI E, DeNicola AL, Yu Y, Verma AK, et al
    Alterations in beta oscillatory activity occur with the emergence of parkinsonian motor signs across the basal ganglia-thalamocortical network.
    Neurobiol Dis. 2025;215:107075.
    PubMed     Abstract available


  5. CHEN T, Gong T, Chen Y, Yang A, et al
    Multimodal MRI biomarkers optimize differentiation between progressive supranuclear palsy and Parkinson's disease.
    Neurobiol Dis. 2025;215:107076.
    PubMed     Abstract available


  6. GRILLO P, Di Martino D, Calculli A, De Icco R, et al
    Physical exercise modulates plasma irisin levels in endurance athletes: Implications for Parkinson's disease.
    Neurobiol Dis. 2025 Aug 23:107065. doi: 10.1016/j.nbd.2025.107065.
    PubMed     Abstract available


  7. LUCAS-DEL-POZO S, Uras G, Fierli F, Lentini V, et al
    Alpha-synuclein inclusions reduced by PIKfyve inhibition in Parkinson's disease cell models.
    Neurobiol Dis. 2025 Aug 12:107053. doi: 10.1016/j.nbd.2025.107053.
    PubMed     Abstract available


  8. BROWN HJ, Fan RZ, Bell R, Salehe SS, et al
    Imbalanced mitochondrial dynamics in human PD and alpha-synuclein mouse brains.
    Neurobiol Dis. 2025;212:106976.
    PubMed     Abstract available


    June 2025
  9. ZHI Y, Chen K, You Y, Ji Y, et al
    Hypo-connected pattern in Parkinson's disease with pure apathy: A dynamic functional connectivity perspective.
    Neurobiol Dis. 2025;213:107008.
    PubMed     Abstract available


  10. ZHU Z, Duanmu X, Zhou C, Wen J, et al
    Glymphatic dysfunction is related to motor disability fully mediated by gray matter degeneration in early-stage Parkinson's disease.
    Neurobiol Dis. 2025;213:107001.
    PubMed     Abstract available


  11. CARRILLO F, Palomba NP, Pietracupa S, Ianiro L, et al
    ANKK1, ANKRD50, GRK5, PACSIN1 and VPS8 are novel candidate genes associated with late onset Parkinson's disease: Definition of a novel predictive protocol based on polygenic model of inheritance.
    Neurobiol Dis. 2025;213:106996.
    PubMed     Abstract available


  12. SUN J, Chen L, Li L, Wu T, et al
    Less locus coeruleus degeneration and its enhanced influence on neural circuit in Parkinson's tremor.
    Neurobiol Dis. 2025 Jun 3:106960. doi: 10.1016/j.nbd.2025.106960.
    PubMed     Abstract available


  13. YIN X, Wang M, Zhao F, Li F, et al
    Choroid plexus area and choroid plexus /lateral ventricle area index are potential imaging markers for freezing of gait in Parkinson's disease.
    Neurobiol Dis. 2025 Jun 2:106984. doi: 10.1016/j.nbd.2025.106984.
    PubMed     Abstract available


    May 2025
  14. FALLETTI M, Asci F, Zampogna A, Patera M, et al
    Cogwheel rigidity in Parkinson's disease: Clinical, biomechanical and neurophysiological features.
    Neurobiol Dis. 2025;212:106980.
    PubMed     Abstract available


  15. PARK G, Ha J, Lee JS, Ahn JH, et al
    Data-driven, cross-sectional image-based subtyping and staging of brain volumetric changes in Parkinson's disease.
    Neurobiol Dis. 2025;212:106970.
    PubMed     Abstract available


  16. CVL D, Munro J, Berard M, Di Paolo T, et al
    Serotonin innervation of the subthalamic nucleus in parkinsonian monkeys.
    Neurobiol Dis. 2025 May 2:106938. doi: 10.1016/j.nbd.2025.106938.
    PubMed     Abstract available


    April 2025
  17. MENG L, Wang D, Ma J, Shi Y, et al
    Unraveling Parkinson's disease motor subtypes: A deep learning approach based on spatiotemporal dynamics of EEG microstates.
    Neurobiol Dis. 2025 Apr 22:106915. doi: 10.1016/j.nbd.2025.106915.
    PubMed     Abstract available


  18. XUE G, Wang G, Shi Q, Wang H, et al
    Exploring the dynamic pathogenesis of Parkinson's disease by case-control and longitudinal blood transcriptome analyses.
    Neurobiol Dis. 2025;209:106891.
    PubMed     Abstract available


  19. WEN S, Li Y, Xiang W, Shen F, et al
    A novel mouse model of chronic neuronopathic Gaucher disease exhibits Parkinson's disease-like phenotypes.
    Neurobiol Dis. 2025;209:106899.
    PubMed     Abstract available


    March 2025
  20. MINGO YB, Escobar Galvis ML, Henderson MX
    alpha-Synuclein pathology and mitochondrial dysfunction: Toxic partners in Parkinson's disease.
    Neurobiol Dis. 2025;209:106889.
    PubMed     Abstract available


  21. YUAN YT, Hong WP, Tan CH, Yu RL, et al
    Influence of WWOX/MAF genes on cognitive performance in patients with Parkinson's disease.
    Neurobiol Dis. 2025;208:106887.
    PubMed     Abstract available


  22. BUONOCORE A, Cafaro C, De Luca C, Vermiglio G, et al
    Lack of pre-movement facilitation as neurophysiological hallmark of fatigue in patients with Parkinson's disease: A single pulse TMS study.
    Neurobiol Dis. 2025;208:106878.
    PubMed     Abstract available


  23. LINAN VS, Rioux V, Peralta M 3rd, Dupre N, et al
    Early detection of Parkinson's disease: Retinal functional impairments as potential biomarkers.
    Neurobiol Dis. 2025 Mar 14:106872. doi: 10.1016/j.nbd.2025.106872.
    PubMed     Abstract available


  24. SUN H, Gan C, Cao X, Yuan Y, et al
    Microstructural and functional abnormalities of the locus coeruleus in freezing of gait in Parkinson's disease.
    Neurobiol Dis. 2025 Mar 9:106868. doi: 10.1016/j.nbd.2025.106868.
    PubMed     Abstract available


  25. WANG B, Gannon M, Pattanayak R, Scholz K, et al
    14-3-3theta phosphorylation exacerbates alpha-synuclein aggregation and toxicity.
    Neurobiol Dis. 2025;206:106801.
    PubMed     Abstract available


    February 2025
  26. WICHMANN T, Nelson A, Torres ERS, Svenningsson P, et al
    Leveraging animal models to understand non-motor symptoms of Parkinson's disease.
    Neurobiol Dis. 2025 Feb 27:106848. doi: 10.1016/j.nbd.2025.106848.
    PubMed     Abstract available


  27. FREDLUND F, Fryklund C, Trujeque-Ramos O, Staley HA, et al
    Lack of neuroprotection after systemic administration of the soluble TNF inhibitor XPro1595 in an rAAV6-alpha-Syn?+?PFFs-induced rat model for Parkinson's disease.
    Neurobiol Dis. 2025 Feb 13:106841. doi: 10.1016/j.nbd.2025.106841.
    PubMed     Abstract available


  28. DIAO Y, Yin Z, Zhao B, Xu Y, et al
    Abnormal neuronal activity in the subthalamic nucleus contributes to dysarthria in patients with Parkinson's disease.
    Neurobiol Dis. 2025 Feb 3:106830. doi: 10.1016/j.nbd.2025.106830.
    PubMed     Abstract available


  29. HARTKE AS, Schreiber CS, Lau K, Wiesweg I, et al
    Alpha-synuclein pathology enhances peripheral and CNS immune responses to bacterial endotoxins.
    Neurobiol Dis. 2025;205:106773.
    PubMed     Abstract available


    January 2025
  30. GUO T, Zhou C, Wen J, Wu J, et al
    Aberrant functional connectome gradient and its neurotransmitter basis in Parkinson's disease.
    Neurobiol Dis. 2025;206:106821.
    PubMed     Abstract available


  31. DEL PERCIO C, Lizio R, Lopez S, Noce G, et al
    Resting-state electroencephalographic rhythms depend on sex in patients with dementia due to Parkinson's and Lewy Body diseases: An exploratory study.
    Neurobiol Dis. 2025;206:106807.
    PubMed     Abstract available


  32. BOLEN ML, Gomes BN, Gill B, Menees KB, et al
    Peripheral blood immune cells from individuals with Parkinson's disease or inflammatory bowel disease share deficits in iron storage and transport that are modulated by non-steroidal anti-inflammatory drugs.
    Neurobiol Dis. 2025 Jan 11:106794. doi: 10.1016/j.nbd.2025.106794.
    PubMed     Abstract available


    December 2024
  33. HUANG CW, Tsai HY, Lin YH, Lin WW, et al
    Striatal-cortical dysconnectivity underlies somatosensory deficits in Parkinson's disease: Insights from rhythmic auditory-motor training.
    Neurobiol Dis. 2024 Dec 22:106778. doi: 10.1016/j.nbd.2024.106778.
    PubMed     Abstract available


    October 2024
  34. LAI MS, Sorensen MH, Lee K, Chu JM, et al
    3D mapping of direct VTA-CA2 circuit with potential involvement in Parkinson's disease degeneration.
    Neurobiol Dis. 2024;202:106723.
    PubMed     Abstract available


  35. CARRILLO F, Palomba NP, Ghirimoldi M, Dido C, et al
    Multiomics approach discloses lipids and metabolites profiles associated to Parkinson's disease stages and applied therapies.
    Neurobiol Dis. 2024 Oct 18:106698. doi: 10.1016/j.nbd.2024.106698.
    PubMed     Abstract available


  36. CAO C, Litvak V, Zhan S, Liu W, et al
    Low-beta versus high-beta band cortico-subcortical coherence in movement inhibition and expectation.
    Neurobiol Dis. 2024;201:106689.
    PubMed     Abstract available


  37. MASSARI CM, Dues DJ, Bergsma A, Sipple K, et al
    Neuropathology in an alpha-synuclein preformed fibril mouse model occurs independent of the Parkinson's disease-linked lysosomal ATP13A2 protein.
    Neurobiol Dis. 2024;202:106701.
    PubMed     Abstract available


  38. MENDONCA MD, Ferreira P, Barbosa R, da Silva JA, et al
    Brain-first forms of Parkinson's disease are over-represented in patients with non-responsive resting tremor.
    Neurobiol Dis. 2024;201:106691.
    PubMed     Abstract available


  39. CHEN B, Zhou H, Liu X, Yang W, et al
    Correlations of gray matter volume with peripheral cytokines in Parkinson's disease.
    Neurobiol Dis. 2024 Oct 3:106693. doi: 10.1016/j.nbd.2024.106693.
    PubMed     Abstract available


    September 2024
  40. LIU J, Ji Z, He Q, Chen H, et al
    Direct conversion of human umbilical cord mesenchymal stem cells into dopaminergic neurons for Parkinson's disease treatment.
    Neurobiol Dis. 2024;201:106683.
    PubMed     Abstract available


  41. SHEN B, Yao Q, Li W, Dong S, et al
    Dynamic cerebellar and sensorimotor network compensation in tremor-dominated Parkinson's disease.
    Neurobiol Dis. 2024;201:106659.
    PubMed     Abstract available


  42. SERMON JJ, Wiest C, Tan H, Denison T, et al
    Evoked resonant neural activity long-term dynamics can be reproduced by a computational model with vesicle depletion.
    Neurobiol Dis. 2024;199:106565.
    PubMed     Abstract available


    August 2024
  43. PARK DG, Kang W, Shin IJ, Chalita M, et al
    Difference in gut microbial dysbiotic patterns between body-first and brain-first Parkinson's disease.
    Neurobiol Dis. 2024;201:106655.
    PubMed     Abstract available


  44. GRENNAN I, Mallet N, Magill PJ, Cagnan H, et al
    Beta bursts in the parkinsonian cortico-basal ganglia network form spatially discrete ensembles.
    Neurobiol Dis. 2024 Aug 27:106652. doi: 10.1016/j.nbd.2024.106652.
    PubMed     Abstract available


  45. STETZIK L, Mercado G, Steiner JA, Lindquist A, et al
    Heterozygous loss of Engrailed-1 and alpha-synucleinopathy (En1/SYN): A dual-hit preclinical mouse model of Parkinson's disease, analyzed with artificial intelligence.
    Neurobiol Dis. 2024 Aug 24:106647. doi: 10.1016/j.nbd.2024.106647.
    PubMed     Abstract available


  46. LI B, Dettmer U
    Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies.
    Neurobiol Dis. 2024 Aug 22:106646. doi: 10.1016/j.nbd.2024.106646.
    PubMed     Abstract available


  47. MASSACCI G, Venafra V, Zwiebel M, Wahle M, et al
    Stage-dependent phosphoproteome remodeling of Parkinson's disease blood cells.
    Neurobiol Dis. 2024;200:106622.
    PubMed     Abstract available


    July 2024
  48. CAMPAGNOLO M, Weis L, Sandre M, Tushevski A, et al
    Immune landscape of the enteric nervous system differentiates Parkinson's disease patients from controls: The PADUA-CESNE cohort.
    Neurobiol Dis. 2024;200:106609.
    PubMed     Abstract available


  49. ADOM MA, Hahn WN, McCaffery TD, Moors TE, et al
    Reducing the lipase LIPE in mutant alpha-synuclein mice improves Parkinson-like deficits and reveals sex differences in fatty acid metabolism.
    Neurobiol Dis. 2024;199:106593.
    PubMed     Abstract available


  50. FASANO A, Mure H, Oyama G, Murase N, et al
    Subthalamic nucleus local field potential stability in patients with Parkinson's disease.
    Neurobiol Dis. 2024;199:106589.
    PubMed     Abstract available


    June 2024
  51. MESAROSOVA L, Scheper M, Iyer A, Anink JJ, et al
    miR-193b-3p/ PGC-1alpha pathway regulates an insulin dependent anti-inflammatory response in Parkinson's disease.
    Neurobiol Dis. 2024 Jun 29:106587. doi: 10.1016/j.nbd.2024.106587.
    PubMed     Abstract available


  52. LI X, Pang H, Bu S, Zhao M, et al
    Stage-dependent differential impact of network communication on cognitive function across the continuum of cognitive decline in Parkinson's disease.
    Neurobiol Dis. 2024 Jun 24:106578. doi: 10.1016/j.nbd.2024.106578.
    PubMed     Abstract available


  53. TEZUKA T, Ishiguro M, Taniguchi D, Osogaguchi E, et al
    Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson's disease.
    Neurobiol Dis. 2024 Jun 18:106571. doi: 10.1016/j.nbd.2024.106571.
    PubMed     Abstract available


  54. MASATO A, Bubacco L
    The alphaSynuclein half-life conundrum.
    Neurobiol Dis. 2024;196:106524.
    PubMed     Abstract available


  55. GAO AYL, Montagna DR, Hirst WD, Temkin PA, et al
    RIT2 regulates autophagy lysosomal pathway induction and protects against alpha-synuclein pathology in a cellular model of Parkinson's disease.
    Neurobiol Dis. 2024;199:106568.
    PubMed     Abstract available


  56. BAARBE J, Brown MJN, Saha U, Tran S, et al
    Cortical modulations before lower limb motor blocks are associated with freezing of gait in Parkinson's disease: an EEG source localization study.
    Neurobiol Dis. 2024 Jun 7:106557. doi: 10.1016/j.nbd.2024.106557.
    PubMed     Abstract available


  57. GAN C, Cao X, Sun H, Ye S, et al
    Multimodal neuroimaging fusion unravel structural-functional-neurotransmitter change in Parkinson's disease with impulse control disorders.
    Neurobiol Dis. 2024;198:106560.
    PubMed     Abstract available


  58. LEAVITT D, Alanazi FI, Al-Ozzi TM, Cohn M, et al
    Auditory oddball responses in the human subthalamic nucleus and substantia nigra pars reticulata.
    Neurobiol Dis. 2024;195:106490.
    PubMed     Abstract available


  59. YAN S, Lu J, Duan B, Zhu H, et al
    Quantitative susceptibility mapping of multiple system atrophy and Parkinson's disease correlates with neurotransmitter reference maps.
    Neurobiol Dis. 2024;198:106549.
    PubMed     Abstract available


    May 2024
  60. CASANOVA F, Tian Q, Williamson DS, Qian Y, et al
    MRI-derived brain iron, grey matter volume, and risk of dementia and Parkinson's disease: Observational and genetic analysis in the UK Biobank cohort.
    Neurobiol Dis. 2024 May 22:106539. doi: 10.1016/j.nbd.2024.106539.
    PubMed     Abstract available


  61. GULBERTI A, Schneider TR, Galindo-Leon EE, Heise M, et al
    Premotor cortical beta synchronization and the network neuromodulation of externally paced finger tapping in Parkinson's disease.
    Neurobiol Dis. 2024 May 11:106529. doi: 10.1016/j.nbd.2024.106529.
    PubMed     Abstract available


  62. SHI D, Wu S, Zhuang C, Mao Y, et al
    Multimodal data fusion reveals functional and neurochemical correlates of Parkinson's disease.
    Neurobiol Dis. 2024 May 11:106527. doi: 10.1016/j.nbd.2024.106527.
    PubMed     Abstract available


  63. ILIEVA NM, Hoffman EK, Ghalib MA, Greenamyre JT, et al
    LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants.
    Neurobiol Dis. 2024 May 3:106522. doi: 10.1016/j.nbd.2024.106522.
    PubMed     Abstract available


  64. HEMBACH S, Schmidt S, Orschmann T, Burtscher I, et al
    Engrailed 1 deficiency induces changes in ciliogenesis during human neuronal differentiation.
    Neurobiol Dis. 2024;194:106474.
    PubMed     Abstract available


    April 2024
  65. GUO X, He S, Geng X, Yao P, et al
    Quantifying local field potential dynamics with amplitude and frequency stability between ON and OFF medication and stimulation in Parkinson's disease.
    Neurobiol Dis. 2024 Apr 27:106519. doi: 10.1016/j.nbd.2024.106519.
    PubMed     Abstract available


  66. RURAK BK, Tan J, Rodrigues JP, Power BD, et al
    Cortico-cortical connectivity is influenced by levodopa in tremor-dominant Parkinson's disease.
    Neurobiol Dis. 2024;196:106518.
    PubMed     Abstract available


  67. TREMBLAY C, Aslam S, Walker JE, Lorenzini I, et al
    RNA sequencing of olfactory bulb in Parkinson's disease reveals gene alterations associated with olfactory dysfunction.
    Neurobiol Dis. 2024 Apr 23:106514. doi: 10.1016/j.nbd.2024.106514.
    PubMed     Abstract available


  68. BUOSO C, Seifert M, Lang M, Griffith CM, et al
    Dopamine?iron homeostasis interaction rescues mitochondrial fitness in Parkinson's disease.
    Neurobiol Dis. 2024 Apr 20:106506. doi: 10.1016/j.nbd.2024.106506.
    PubMed     Abstract available


  69. TONG B, Ba Y, Li Z, Yang C, et al
    Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects.
    Neurobiol Dis. 2024 Apr 18:106505. doi: 10.1016/j.nbd.2024.106505.
    PubMed     Abstract available


  70. JIAO LL, Dong HL, Liu MM, Wu PL, et al
    The potential roles of salivary biomarkers in neurodegenerative diseases.
    Neurobiol Dis. 2024;193:106442.
    PubMed     Abstract available


    March 2024
  71. IOVINO L, Vander Zwaag J, Kaur G, Khakpour M, et al
    Investigation of microglial diversity in a LRRK2 G2019S mouse model of Parkinson's disease.
    Neurobiol Dis. 2024 Mar 23:106481. doi: 10.1016/j.nbd.2024.106481.
    PubMed     Abstract available


  72. ZHOU C, You J, Guan X, Guo T, et al
    Microstructural alterations of the hypothalamus in Parkinson's disease and probable REM sleep behavior disorder.
    Neurobiol Dis. 2024 Mar 11:106472. doi: 10.1016/j.nbd.2024.106472.
    PubMed     Abstract available


    February 2024
  73. HUANG YT, Chen YW, Lin TY, Chen JC, et al
    Suppression of presynaptic corticostriatal glutamate activity attenuates L-dopa-induced dyskinesia in 6-OHDA-lesioned Parkinson's disease mice.
    Neurobiol Dis. 2024;193:106452.
    PubMed     Abstract available


  74. STOLL AC, Kemp CJ, Patterson JR, Howe JW, et al
    Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions.
    Neurobiol Dis. 2024;191:106411.
    PubMed     Abstract available


    January 2024
  75. IMARISIO A, Yahyavi I, Avenali M, Di Maio A, et al
    Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson's disease.
    Neurobiol Dis. 2024;192:106413.
    PubMed     Abstract available


  76. WU C, Wu H, Zhou C, Guan X, et al
    Neurovascular coupling alteration in drug-naive Parkinson's disease: The underlying molecular mechanisms and levodopa's restoration effects.
    Neurobiol Dis. 2024 Jan 8:106406. doi: 10.1016/j.nbd.2024.106406.
    PubMed     Abstract available


  77. SALIN P, Melon C, Chassain C, Gubellini P, et al
    Interhemispheric reactivity of the subthalamic nucleus sustains progressive dopamine neuron loss in asymmetrical parkinsonism.
    Neurobiol Dis. 2024;191:106398.
    PubMed     Abstract available


    December 2023
  78. TRAN S, Heida TC, Heijs JJA, Al-Ozzi T, et al
    Subthalamic and pallidal neurons are modulated during externally cued movements in Parkinson's disease.
    Neurobiol Dis. 2023 Dec 20:106384. doi: 10.1016/j.nbd.2023.106384.
    PubMed     Abstract available


  79. LIANG K, Li X, Guo Q, Ma J, et al
    Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
    Neurobiol Dis. 2023;190:106379.
    PubMed     Abstract available


  80. DI LAZZARO G, Picca A, Boldrini S, Bove F, et al
    Differential profiles of serum cytokines in Parkinson's disease according to disease duration.
    Neurobiol Dis. 2023 Dec 5:106371. doi: 10.1016/j.nbd.2023.106371.
    PubMed     Abstract available


    November 2023
  81. TSHILENGE KT, Bons J, Aguirre CG, Geronimo-Olvera C, et al
    Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing.
    Neurobiol Dis. 2023 Nov 30:106367. doi: 10.1016/j.nbd.2023.106367.
    PubMed     Abstract available


  82. TOFFOLI M, Chohan H, Mullin S, Jesuthasan A, et al
    Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study.
    Neurobiol Dis. 2023 Nov 3:106343. doi: 10.1016/j.nbd.2023.106343.
    PubMed     Abstract available


  83. HARVEY J, Pishva E, Chouliaras L, Lunnon K, et al
    Elucidating distinct molecular signatures of Lewy body dementias.
    Neurobiol Dis. 2023;188:106337.
    PubMed     Abstract available


  84. TUBERT C, Zampese E, Pancani T, Tkatch T, et al
    Feed-forward metabotropic signaling by Cav1 Ca(2+) channels supports pacemaking in pedunculopontine cholinergic neurons.
    Neurobiol Dis. 2023;188:106328.
    PubMed     Abstract available


  85. DUES DJ, Ma Y, Nguyen APT, Offerman AV, et al
    Formation of templated inclusions in a forebrain alpha-synuclein mouse model is independent of LRRK2.
    Neurobiol Dis. 2023;188:106338.
    PubMed     Abstract available


    October 2023
  86. RIVAS-SANTISTEBAN R, Rico A, Munoz A, Rodriguez AI, et al
    Boolean analysis shows a high proportion of dopamine D(2) receptors interacting with adenosine A(2A) receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease.
    Neurobiol Dis. 2023 Oct 31:106341. doi: 10.1016/j.nbd.2023.106341.
    PubMed     Abstract available


  87. CHEN L, Sun J, Gao L, Wang J, et al
    Dysconnectivity of the parafascicular nucleus in Parkinson's disease: A dynamic causal modeling analysis.
    Neurobiol Dis. 2023;188:106335.
    PubMed     Abstract available


  88. LI T, Liu T, Zhang J, Ma Y, et al
    Neurovascular coupling dysfunction of visual network organization in Parkinson's disease.
    Neurobiol Dis. 2023;188:106323.
    PubMed     Abstract available


  89. MAPLE-GRODEM J, Ushakova A, Pedersen KF, Tysnes OB, et al
    Identification of diagnostic and prognostic biomarkers of PD using a multiplex proteomics approach.
    Neurobiol Dis. 2023;186:106281.
    PubMed     Abstract available


  90. SCHAFFNER SL, Wassouf Z, Hentrich T, Nuesch-Germano M, et al
    Distinct impacts of alpha-synuclein overexpression on the hippocampal epigenome of mice in standard and enriched environments.
    Neurobiol Dis. 2023;186:106274.
    PubMed     Abstract available


    September 2023
  91. DE FABREGUES O, Selles M, Ramos-Vicente D, Roch G, et al
    Relevance of tissue-resident memory CD8 T cells in the onset of Parkinson's disease and examination of its possible etiologies: infectious or autoimmune?
    Neurobiol Dis. 2023 Sep 21:106308. doi: 10.1016/j.nbd.2023.106308.
    PubMed     Abstract available


  92. TRINH D, Israwi AR, Brar H, Villafuerte JEA, et al
    Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy.
    Neurobiol Dis. 2023 Sep 11:106287. doi: 10.1016/j.nbd.2023.106287.
    PubMed     Abstract available


    August 2023
  93. GRONLIER E, Volle J, Coizet V, Paccard A, et al
    Evoked responses to single pulse electrical stimulation reveal impaired striatal excitability in a rat model of Parkinson's disease.
    Neurobiol Dis. 2023 Aug 19:106266. doi: 10.1016/j.nbd.2023.106266.
    PubMed     Abstract available


  94. GAN C, Ji M, Sun H, Cao X, et al
    Dynamic functional connectivity reveals hyper-connected pattern and abnormal variability in freezing of gait of Parkinson's disease.
    Neurobiol Dis. 2023;185:106265.
    PubMed     Abstract available


  95. REN J, Yan L, Zhou H, Pan C, et al
    Unraveling neurotransmitter changes in de novo GBA-related and idiopathic Parkinson's disease.
    Neurobiol Dis. 2023 Aug 7:106254. doi: 10.1016/j.nbd.2023.106254.
    PubMed     Abstract available


  96. DUMONT M, Agostinis A, Singh K, Swan E, et al
    Sex representation in neurodegenerative and psychiatric disorders' preclinical and clinical studies.
    Neurobiol Dis. 2023;184:106214.
    PubMed     Abstract available


  97. BHATIA TN, Jamenis AS, Abbas M, Clark RN, et al
    A 14-day pulse of PLX5622 modifies alpha-synucleinopathy in preformed fibril-infused aged mice of both sexes.
    Neurobiol Dis. 2023;184:106196.
    PubMed     Abstract available


    July 2023
  98. CROCKETT RA, Wilkins KB, Aditham S, Bronte-Stewart HM, et al
    No laughing white matter: Reduced integrity of the cortical cholinergic pathways in Parkinson's disease-related cognitive impairment.
    Neurobiol Dis. 2023 Jul 29:106243. doi: 10.1016/j.nbd.2023.106243.
    PubMed     Abstract available


  99. URSO D, Batzu L, Logroscino G, Chaudhuri KR, et al
    Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson's disease.
    Neurobiol Dis. 2023 Jul 25:106237. doi: 10.1016/j.nbd.2023.106237.
    PubMed     Abstract available


  100. AVANTAGGIATO F, Farokhniaee A, Bandini A, Palmisano C, et al
    Intelligibility of speech in Parkinson's disease relies on anatomically segregated subthalamic beta oscillations.
    Neurobiol Dis. 2023 Jul 25:106239. doi: 10.1016/j.nbd.2023.106239.
    PubMed     Abstract available


  101. WANG Y, Xia Y, Kou L, Yin S, et al
    Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson's disease.
    Neurobiol Dis. 2023 Jul 9:106224. doi: 10.1016/j.nbd.2023.106224.
    PubMed     Abstract available


  102. LEGAZ A, Prado P, Moguilner S, Baez S, et al
    Social and non-social working memory in neurodegeneration.
    Neurobiol Dis. 2023;183:106171.
    PubMed     Abstract available


    June 2023
  103. WU H, Wu C, Qin J, Zhou C, et al
    Functional connectome predicting individual gait function and its relationship with molecular architecture in Parkinson's disease.
    Neurobiol Dis. 2023;184:106216.
    PubMed     Abstract available


  104. DI MAIO A, Nuzzo T, Gilio L, Serra M, et al
    Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients.
    Neurobiol Dis. 2023 Jun 17:106203. doi: 10.1016/j.nbd.2023.106203.
    PubMed     Abstract available


  105. BATZU L, Urso D, Grothe MJ, Vereb D, et al
    Increased basal forebrain volumes could prevent cognitive decline in LRRK2 Parkinson's disease.
    Neurobiol Dis. 2023 Jun 5:106182. doi: 10.1016/j.nbd.2023.106182.
    PubMed     Abstract available


  106. ZHONG M, Wang Y, Lin G, Liao FF, et al
    Dopamine-independent development and maintenance of mouse striatal medium spiny neuron dendritic spines.
    Neurobiol Dis. 2023;181:106096.
    PubMed     Abstract available


    May 2023
  107. LUCHETTI S, Liere P, Pianos A, Verwer RWH, et al
    Disease stage-dependent changes in brain levels and neuroprotective effects of neuroactive steroids in Parkinson's disease.
    Neurobiol Dis. 2023 May 29:106169. doi: 10.1016/j.nbd.2023.106169.
    PubMed     Abstract available


  108. YIN Z, Jiang Y, Merk T, Neumann WJ, et al
    Pallidal activities during sleep and sleep decoding in dystonia, Huntington's, and Parkinson's disease.
    Neurobiol Dis. 2023 May 3:106143. doi: 10.1016/j.nbd.2023.106143.
    PubMed     Abstract available


  109. FAYARD A, Fenyi A, Lavisse S, Dovero S, et al
    Functional and neuropathological changes induced by injection of distinct alpha-synuclein strains: A pilot study in non-human primates.
    Neurobiol Dis. 2023;180:106086.
    PubMed     Abstract available


  110. CHEN Z, Reynolds RH, Pardinas AF, Gagliano Taliun SA, et al
    The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases.
    Neurobiol Dis. 2023;180:106082.
    PubMed     Abstract available


    April 2023
  111. GUERRA A, Colella D, Cannavacciuolo A, Giangrosso M, et al
    Short-term plasticity of the motor cortex compensates for bradykinesia in Parkinson's disease.
    Neurobiol Dis. 2023;182:106137.
    PubMed     Abstract available


  112. HAYLEY S, Vahid-Ansari F, Sun H, Albert PR, et al
    Mood disturbances in Parkinson's disease: From prodromal origins to application of animal models.
    Neurobiol Dis. 2023 Apr 8:106115. doi: 10.1016/j.nbd.2023.106115.
    PubMed     Abstract available


  113. SASIKUMAR S, Sorrento G, Lang AE, Strafella AP, et al
    Cognition affects gait adaptation after split-belt treadmill training in Parkinson's disease.
    Neurobiol Dis. 2023 Apr 3:106109. doi: 10.1016/j.nbd.2023.106109.
    PubMed     Abstract available


    March 2023
  114. CAULFIELD ME, Vander Werp MJ, Stancati JA, Collier TJ, et al
    Downregulation of striatal Ca(V)1.3 inhibits the escalation of levodopa-induced dyskinesia in male and female parkinsonian rats of advanced age.
    Neurobiol Dis. 2023 Mar 29:106111. doi: 10.1016/j.nbd.2023.106111.
    PubMed     Abstract available


  115. HUANG Q, Chen C, Chen W, Cai C, et al
    Cell type- and region-specific translatomes in an MPTP mouse model of Parkinson's disease.
    Neurobiol Dis. 2023;180:106105.
    PubMed     Abstract available


  116. TAN S, Zhou C, Wen J, Duanmu X, et al
    Presence but not the timing of onset of REM sleep behavior disorder distinguishes evolution patterns in Parkinson's disease.
    Neurobiol Dis. 2023;180:106084.
    PubMed     Abstract available


  117. PORRINI V, Pilotto A, Vezzoli M, Lanzillotta A, et al
    NF-kappaB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients.
    Neurobiol Dis. 2023 Mar 7:106067. doi: 10.1016/j.nbd.2023.106067.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.